Phase II EORTC trial with 5-fluorouracil, cisplatin and interferon-α as second-line treatment of advanced transitional cell cancer of the urothelial tract
- P. H.M. De Mulder
- , C. Theodore
- , A. Sella
- , O. Koriakine
- , C. N. Sternberg
- , L. Collette
- , C. De Balincourt
Research output: Contribution to journal › Article › peer-review
22
Scopus
citations